Azacitidine upregulates TNFSF4 gene expression in leukemia cells, increasing OX40L production. OX40L binds to OX40 receptors on CAR T cells, activating costimulatory signals that enhance CAR T cell proliferation, effector differentiation, and long-term survival. This evidence concerns the gene TNFSF4 and leukemia.